C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/53 (2006.01) A61P 25/24 (2006.01) G01N 33/566 (2006.01) G01N 33/567 (2006.01) G01N 33/58 (2006.01)
Patent
CA 2440553
Corticotropin releasing factor (CRF) antagonists of Formula (I), and its use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
L'invention concerne des antagonistes de corticolibérine (CRF) de formule (I) et leur utilisation dans le traitement de l'anxiété, de la dépression et d'autres troubles psychiatriques neurologiques ainsi que le traitement de maladies liées au système immunologique, cardiovasculaire ou cardiaque et de l'hypersensibilité colique associée à des troubles psychologiques et au stress.
Bristol-Myers Squibb Pharma Company
Gowling Lafleur Henderson Llp
LandOfFree
4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-y... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-y..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-y... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2077424